Filter

  • Advanced Filters:

  • to
  • Specific Data Sources:

    All Edit

    Select All  |  Select None

Reset filters

DeepDyve - Search, Rent, Read
The easiest way for you to get scholarly articles:

  • Millions of articles from over 6,000 authoritative journals.
  • Get any 40 rentable articles for just $40 a month.
  • Read rented articles for an entire year.
  • Unused rentals get rolled over.

Bookmark

Use of Serum Biomarkers to Predict Cerebral Hypoxia After Severe Traumatic Brain Injury

Preview Only

Use of Serum Biomarkers to Predict Cerebral Hypoxia After Severe Traumatic Brain Injury

Abstract

The management of severe traumatic brain injury (TBI) focuses on prevention and treatment of secondary insults such as cerebral hypoxia (CH). There are a number of biomarkers that are thought to play a part in secondary injury following severe TBI. This study evaluates the association between S100β, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), detected in the serum of severe TBI patients and CH as measured by brain tissue oxygen partial pressure (Pb o 2 ). Patients with severe TBI were prospectively enrolled. Pressure times time (PTD; mm Hg*h), measuring the depth and duration of CH, was calculated for 12-h periods for episodes of moderate (Pb o 2 < 20 mm Hg) and severe (Pb o 2 < 15 mm Hg) CH, and compared to serum levels of S100β, NSE, and GFAP drawn prior to periods of monitoring. An adjusted mixed model analysis was applied as was receiver operating characteristic (ROC) curve analysis. Of 76 patients enrolled, 24 had Pb o 2 monitoring. One hundred and thirty serum samples were matched with 12-h periods of monitoring. Significant associations were found in adjusted analyses between increasing serum levels of S100β (coefficient=0.57, 0.56; p <0.001), NSE (coefficient=0.48, 0.52; p <0.001), and GFAP (coefficient=0.29, 0.30; p =0.003 and 0.002), and increasing PTD of moderate (Pb o 2 <20 mm Hg) and severe (Pb o 2 <15 mm Hg) CH. AUCs for the prediction of moderate and severe CH were 0.62 and 0.66 for S100β, 0.55 and 0.71 for NSE, and 0.50 and 0.62 for GFAP, respectively. Specificities were between 76% and 90% for S100β and NSE. S100β, NSE, and GFAP demonstrate promise as candidate serum markers of impending CH. The fact that these biomarker elevations occur prior to the onset of clinical manifestations suggests that we may be able to predict imminent events following TBI. Given the morbidity of CH, early intervention and prevention may have a significant impact on outcomes and help guide decisions about the timing of interventions.
Loading next page...
1 Page

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/mary-ann-liebert/use-of-serum-biomarkers-to-predict-cerebral-hypoxia-after-severe-0Gf0JGXnWi
Title
Use of Serum Biomarkers to Predict Cerebral Hypoxia After Severe Traumatic Brain Injury
Author(s)
Stein, Deborah M.; Lindell, Allison L.; Murdock, Karen R.; Kufera, Joseph A.; Menaker, Jay; Bochicchio, Grant V.; Aarabi, Bizhan; Scalea, Thomas M.
Journal
Journal of Neurotrauma , Volume 0 (0) Mary Ann Liebert – Jan 1, 2012
Publisher
Mary Ann Liebert, Inc.
Copyright
Copyright 2012, Mary Ann Liebert, Inc.
ISSN
0897-7151
eISSN
1557-9042
D.O.I.
10.1089/neu.2011.2149
Publisher site
Get PDF